Animal Models of T Cell-Mediated Skin Diseases

Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Zollner, T. (Editor), Renz, H. (Editor), Asadullah, K. (Editor)
Format: Electronic eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg, 2005.
Series:Ernst Schering Research Foundation Workshop, 50
Subjects:
Online Access:Full Text via HEAL-Link

Similar Items